Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed Acute Promyelocytic Leukemia (APL)

NCT00591526 is registered in ClinicalTrials.gov with Groupe d'etude et de travail sur les leucemies aigues promyelocytaires as lead sponsor.

NCT NCT00591526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00591526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed Acute Promyelocytic Leukemia (APL)
Lead sponsor
Groupe d'etude et de travail sur les leucemies aigues promyelocytaires
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2000
Completion date
June 30, 2004
Enrollment
250 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, promyelocytic, acute